Just one thing to say..., page-3

First 3 Last

Share
Profile

Follow
Dommy1903

82 Posts.

13

02/08/23

23:52

Post #: 69125503
Share

Originally posted by Schmidlap: ↑

Yep I agree.
If there is one share on this forum that has been a flogging to read over the years it is MSB. Nervous nellies we all are, but trying to predict the future is always dangerous and a total waste of time.

For those providing objective and factual information on here during the ups and downs over the years, thank you as perspective is what a forum is meant to provide. You can be a holder and be objective and express excitement on one side and doubt on the other relating to a companies prospects, that is fair and reasonable, as long as it is realistic. I must say most posters here keep it factual when discussing events and prospects.

However, on HC the number of total deadbeats (who I don't mind saying are really sick in the head and pretty much sociopathic), that have intentionally bred fear and distrust, anxiety and angst for no good reason other than to either profit financially through their downramping activities, or just get kicks out of arguing because they reckon they're right, well I feel that life has a way of humbling people like you and I hope it does.

MSB is a company trying to do something great and meaningful, most SH in this company are aware of this and embrace it. If the FDA doesn't agree with that prospect, then so be it, they are the umpire in this field. For people to want the company to fail (an Australian company that would save children's lives and quality of life around the world and boost our economy and earnings in the process) well, that is just shite. You should be embarrassed with who you are.

Good luck tomorrow, to the sick, those that run the company to change modern medicine and those who invested and believe.

Expand

Well said!!

MSB Price at posting: $1.09 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Essential Energy conference: Streamlining approvals key to the green energy transition

There are more pages in this discussion • 6 more messages in this thread...

First 3 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 92.3¢		Change -0.003(0.27%)		Mkt cap ! $1.053B

Open	High	Low	Value	Volume
92.0¢	92.5¢	91.5¢	$768.3K	835.4K

Buyers (Bids)

No.	Vol.	Price($)
6	20502	92.0¢

Sellers (Offers)

Price($)	Vol.	No.
92.5¢	159360	48

View Market Depth

No.	Vol.	Price($)
15	70355	0.920
33	310461	0.915
22	187463	0.910
8	62929	0.905
45	366436	0.900

Price($)	Vol.	No.
0.925	155987	46
0.930	109314	16
0.935	129787	8
0.940	18060	5
0.945	59774	3

Last trade - 14.41pm 18/09/2024 (20 minute delay)

MSB (ASX) Chart

Just one thing to say..., page-3

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Essential Energy conference: Streamlining approvals key to the green energy transition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Just one thing to say..., page-3

Top Stories

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Essential Energy conference: Streamlining approvals key to the green energy transition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News